Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

Minh PLê; LindaBelarbi; Marie-LaureChaix; EmmanuelDulioust; NadiaMahjoub; DominiqueSalmon; Jean-PaulViard; ClaudineDuvivier; GillesPeytavin; OdileLaunay; JadeGhosn

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

【24h】

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

机译：来自艾滋病毒治疗含有这些抗逆转录患者的艾滋病毒阳性患者的雌性和雄性生殖器中的总和未结合的Maraviroc，RALTEGRAVIR和瑞培患者的渗透和抗病毒疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2017年第11期|共5页
作者
Minh PLê; LindaBelarbi; Marie-LaureChaix; EmmanuelDulioust; NadiaMahjoub; DominiqueSalmon; Jean-PaulViard; ClaudineDuvivier; GillesPeytavin; OdileLaunay; JadeGhosn;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献

1. Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals [J] . Minh PLê, LindaBelarbi, Marie-LaureChaix, The Journal of Antimicrobial Chemotherapy . 2017,第11期

机译：来自艾滋病毒治疗含有这些抗逆转录患者的艾滋病毒阳性患者的雌性和雄性生殖器中的总和未结合的Maraviroc，RALTEGRAVIR和瑞培患者的渗透和抗病毒疗效
2. New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir. [J] . Hughes CA, Robinson L, Tseng A, Expert opinion on pharmacotherapy . 2009,第15期

机译：新的抗逆转录病毒药物：对Tipranavir，Darunavir，etravirine，Rilpivirine，Maraviroc和Raltegravir的疗效，安全性，药代动力学和抗性剖面综述。
3. New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir. [J] . Hughes CA, Robinson L, Tseng A, Expert opinion on pharmacotherapy . 2009,第15期

机译：新的抗逆转录病毒药物：对Tipranavir，Darunavir，etravirine，Rilpivirine，Maraviroc和Raltegravir的疗效，安全性，药代动力学和抗性剖面综述。
4. Efficacy and safety in clinical practice of a rilpivirine tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy [O] . Nicola Gianotti, Andrea Poli, Silvia Nozza, 2015

机译：瑞匹韦林替诺福韦和恩曲他滨单片方案在稳定抗病毒治疗后被病毒学抑制的HIV阳性患者的临床疗效和安全性
5. Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy [O] . Nicola Gianotti, Andrea Poli, Silvia Nozza, 2015

机译：利福韦林，替诺福韦和恩曲他滨单片治疗方案在病毒学抑制的HIV阳性患者中进行稳定抗逆转录病毒疗法的临床实践中的有效性和安全性

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

著录项

相似文献

相关主题

期刊订阅